Assessment of Coagulation and Fibrinolysis in Pre-eclampsia

Overview

Journal Br Med J

Specialty General Medicine

Date 1974 Apr 20

PMID 4596483

Citations 1

Authors

S M Wood

D Burnett

A M Picken

G W Farrell

P Wolf

Affiliations

Soon will be listed here.

Abstract

A method is described for distinguishing coagulation from fibrinolysis by three estimates of fibrinogen. This "fibrinogen series" together with plasma antithrombin and urinary urokinase have been compared in pregnant patients with venous thrombosis and pre-eclampsia. Evidence is presented for active coagulation during deterioration of the pre-eclampsia state and for enhanced fibrinolysis during improvement.

Citing Articles

Nephrotic syndrome, sickle-cell disease and pregnancy.

Smith A Postgrad Med J. 1976; 52(612):665-8.

PMID: 995796 PMC: 2496359. DOI: 10.1136/pgmj.52.612.665.

References

Howie P, Prentice C, McNicol G . Coagulation, fibrinolysis and platelet function in pre-eclampsia, essential hypertension and placental insufficiency. J Obstet Gynaecol Br Commonw. 1971; 78(11):992-1003. DOI: 10.1111/j.1471-0528.1971.tb00216.x. View

Wolf P, Farrell G, Walton K . The significance of variations in immunoreactive and clottable fibrinogen in health and following thrombosis. J Clin Pathol. 1972; 25(1):36-44. PMC: 477218. DOI: 10.1136/jcp.25.1.36. View

Farrell G, Wolf P . Immunoephelometric determination of fibrinogen and its derivatives in plasma. J Immunol Methods. 1972; 1(3):217-29. DOI: 10.1016/0022-1759(72)90001-4. View

Farrell G, Wolf P . A batch method for estimating thrombin clottable fibrinogen. J Clin Pathol. 1973; 26(10):764-9. PMC: 477878. DOI: 10.1136/jcp.26.10.764. View

Bonnar J, Davidson J, Pidgeon C, McNicol G, Douglas A . Fibrin degradation products in normal and abnormal pregnancy and parturition. Br Med J. 1969; 3(5663):137-40. PMC: 1983920. DOI: 10.1136/bmj.3.5663.137. View

PRITCHARD J, Ratnoff O, WEISMAN Jr R . Hemostatic defects and increased red cell destruction in pre-eclampsia and eclampsia. Obstet Gynecol. 1954; 4(2):159-64. View

Henderson A, Pugsley D, Thomas D . Fibrin degradation products in pre-eclamptic toxaemia and eclampsia. Br Med J. 1970; 3(5722):545-7. PMC: 1701571. DOI: 10.1136/bmj.3.5722.545. View

Farrell G, Wolf P . The measurement of fibrinogen and its derivatives. 3. Thrombin clottable fibrinogen estimates in the presence of epsilon amino caproic acid, fibrinogen and fibrin degradation products. Med Lab Technol. 1971; 28(3):328-36. View

PAGE E . On the pathogenesis of pre-eclampsia and eclampsia. J Obstet Gynaecol Br Commonw. 1972; 79(10):883-94. DOI: 10.1111/j.1471-0528.1972.tb12184.x. View

10.

SHAINOFF J, PAGE I . Significance of cryoprofibrin in fibrinogen-fibrin conversion. J Exp Med. 1962; 116:687-707. PMC: 2137554. DOI: 10.1084/jem.116.5.687. View

11.

Wardle E, Menon I . Fibrinolysis in pre-eclamptic toxaemia of pregnancy. Br Med J. 1969; 2(5657):625-7. PMC: 1983642. DOI: 10.1136/bmj.2.5657.625. View